Literature DB >> 8241951

Effects of macrophage colony stimulating factor and granulocyte-macrophage colony stimulating factor on osteoclastic differentiation of hematopoietic progenitor cells.

W Liggett1, N Shevde, P Anklesaria, S Sohoni, J Greenberger, J Glowacki.   

Abstract

Although the hematopoietic origin of the osteoclast is generally accepted, the precise phenotype of the progenitor and the regulation of its differentiation are unclear. This study compares proliferation and differentiation of progenitors in response to macrophage colony stimulating factor (M-CSF) and granulocyte macrophage colony stimulating factor (GM-CSF). Nonadherent progenitor cells from murine long-term bone marrow cultures (LTBMC) (as a source of osteoclast progenitors) demonstrated a significant proliferative response to M-CSF. In addition, M-CSF increased the number of multinucleated cells, only a small percent of which (14-16%) were tartrate-resistant, acid phosphatase (TRAP)-positive. In contrast, cells cultured with GM-CSF generated more TRAP-positive multinucleated cells even at concentrations less stimulatory of proliferation than M-CSF. The osteoclast phenotype of these multinucleated cells was also assessed by ultrastructural characterization of ruffled borders in association with bone fragments. The bone-active hormone 1,25-dihydroxyvitamin D3 inhibited the proliferation of this subset of progenitor cells in the presence of M-CSF or GM-CSF. All of these results show effects on progenitors in the absence of the stromal cell microenvironment in this system. These results provide evidence for a divergence in the biological responsiveness of osteoclast progenitor cells to M-CSF compared with GM-CSF; they support the notion that M-CSF has a "priming" effect on osteoclast progenitors whose subsequent differentiation to osteoclastic multinucleated cells is promoted by GM-CSF.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8241951     DOI: 10.1002/stem.5530110507

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  12 in total

Review 1.  Osteoblast responses to bacterial pathogens: a previously unappreciated role for bone-forming cells in host defense and disease progression.

Authors:  Ian Marriott
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 2.  The pathophysiology and management of spine metastasis from lung cancer.

Authors:  J S Greenberger
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

3.  Cytotoxic effects of Kingella kingae outer membrane vesicles on human cells.

Authors:  R Maldonado; R Wei; S C Kachlany; M Kazi; N V Balashova
Journal:  Microb Pathog       Date:  2011-04-02       Impact factor: 3.738

4.  Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture.

Authors:  Y Okada; J A Lorenzo; A M Freeman; M Tomita; S G Morham; L G Raisz; C C Pilbeam
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

5.  Induction of colony-stimulating factor expression following Staphylococcus or Salmonella interaction with mouse or human osteoblasts.

Authors:  K L Bost; J L Bento; J K Ellington; I Marriott; M C Hudson
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

6.  Reduced osteoclastogenesis and RANKL expression in marrow from women taking alendronate.

Authors:  Behnam Eslami; Shuanhu Zhou; Inge Van Eekeren; Meryl S LeBoff; Julie Glowacki
Journal:  Calcif Tissue Int       Date:  2011-02-15       Impact factor: 4.333

7.  Granulocyte/macrophage colony-stimulating factor and interleukin-3 correct osteopetrosis in mice with osteopetrosis mutation.

Authors:  Y Y Myint; K Miyakawa; M Naito; L D Shultz; Y Oike; K Yamamura; K Takahashi
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

8.  Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.

Authors:  S-M Dai; K Nishioka; K Yudoh
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

9.  Thrombopoietin expands erythroid progenitors, increases red cell production, and enhances erythroid recovery after myelosuppressive therapy.

Authors:  K Kaushansky; V C Broudy; A Grossmann; J Humes; N Lin; H P Ren; M C Bailey; T Papayannopoulou; J W Forstrom; K H Sprugel
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

10.  c-Fms signaling mediates neurofibromatosis Type-1 osteoclast gain-in-functions.

Authors:  Yongzheng He; Steven D Rhodes; Shi Chen; Xiaohua Wu; Jin Yuan; Xianlin Yang; Li Jiang; Xianqi Li; Naoyuki Takahashi; Mingjiang Xu; Khalid S Mohammad; Theresa A Guise; Feng-Chun Yang
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.